Literature DB >> 16127570

[Second Brazilian Consensus Conference on Helicobacter pylori infection].

Luiz Gonzaga Vaz Coelho1, Schlioma Zaterka.   

Abstract

Significant progress has been obtained since the First Brazilian Consensus Conference on H. pylori Infection held in 1995, in Belo Horizonte, MG, and justify a second meeting to establish updated guidelines on the current management of H. pylori infection. The Second Brazilian Consensus Conference on H. pylori Infection was organized by the Brazilian Federation of Gastroenterology and Brazilian Nucleus for the Study of Helicobacter and took place on June, 19-20, 2004 in São Paulo, SP. Thirty six delegates coming from 15 different Brazilian states including gastroenterologists, pathologists, microbiologists and pediatricians undertook the meeting. The participants were allocated in one the five main topics of the meeting: H. pylori and dyspepsia, H. pylori and NSAIDs, H. pylori and gastroesophageal reflux disease, H. pylori treatment, and H. pylori retreatment. Seventy per cent and more votes were considered as acceptance for the final statement. The results were presented during a special session on the VI Brazilian Week of Digestive System, in Recife, PE (October 2004), and this publication represents the summary of the main recommendations and conclusions emerged from the meeting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127570     DOI: 10.1590/s0004-28032005000200012

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  13 in total

1.  Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?

Authors:  Carlos Robles-Jara; Carlos Robles-Medranda; Manuel Moncayo; Byron Landivar; Johnny Parrales
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 2.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Furazolidone-based triple therapy for H pylori gastritis in children.

Authors:  Elisabete Kawakami; Rodrigo Strehl Machado; Silvio Kazuo Ogata; Marini Langner; Erika Fukushima; Anna Paula Carelli; Vania Cláudia Guimarães Bonucci; Francy Reis Silva Patricio
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

4.  Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma.

Authors:  Jose Luiz Bertoli Neto; Laercio Gomes Lourenço; Cícero Fernando Bertoli; Fábio Samsonowski Ulbrich; Antoninho Ricardo Sabbi; Alexandre Galvão Bueno
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

5.  INFLAMMATORY DISORDERS ASSOCIATED WITH HELICOBACTER PYLORI IN THE ROUX-EN-Y BYPASS GASTRIC POUCH.

Authors:  Luiz Claudio Lopes Chaves; Isabela Klautau Leite Chaves Borges; Maíra Danielle Gomes de Souza; Ian Passos Silva; Lyz Bezerra Silva; Marcelo Alexandre Prado Magalhães; Allan Herbert Feliz Fonseca; Josemberg Marins Campos
Journal:  Arq Bras Cir Dig       Date:  2016

6.  Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil.

Authors:  Rodrigo Buzinaro Suzuki; Cristiane Maria Almeida; Márcia Aparecida Sperança
Journal:  BMC Gastroenterol       Date:  2012-05-17       Impact factor: 3.067

7.  Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Tomás Navarro-Rodriguez; Fernando Marcuz Silva; Ricardo Correa Barbuti; Rejane Mattar; Joaquim Prado Moraes-Filho; Maricê Nogueira de Oliveira; Cristina S Bogsan; Décio Chinzon; Jaime Natan Eisig
Journal:  BMC Gastroenterol       Date:  2013-03-26       Impact factor: 3.067

8.  Evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens of dyspeptic patients.

Authors:  Ivy Bastos Ramis; Ernani Pinho de Moraes; Márcia Silveira Fernandes; Raul Mendoza-Sassi; Obirajara Rodrigues; Carlos Renan Varela Juliano; Carlos James Scaini; Pedro Eduardo Almeida da Silva
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

9.  Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.

Authors:  Jaime N Eisig; Fernando M Silva; Ricardo C Barbuti; Tomás Navarro Rodriguez; Peter Malfertheiner; Joaquim P P Moraes Filho; Schlioma Zaterka
Journal:  BMC Gastroenterol       Date:  2009-05-26       Impact factor: 3.067

10.  Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy.

Authors:  Fernando M Silva; Jaime N Eisig; Ana Cristina S Teixeira; Ricardo C Barbuti; Tomás Navarro-Rodriguez; Rejane Mattar
Journal:  BMC Gastroenterol       Date:  2008-05-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.